Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Immunome (IMNM) Assets Average (2023 - 2025)

Immunome (IMNM) has disclosed Assets Average for 3 consecutive years, with $491.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average rose 97.64% year-over-year to $491.3 million, compared with a TTM value of $491.3 million through Dec 2025, up 97.64%, and an annual FY2025 reading of $461.7 million, up 137.52% over the prior year.
  • Assets Average was $491.3 million for Q4 2025 at Immunome, up from $297.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $491.3 million in Q4 2025 and bottomed at $44.8 million in Q2 2023.
  • Average Assets Average over 3 years is $245.5 million, with a median of $276.6 million recorded in 2024.
  • The sharpest move saw Assets Average surged 587.86% in 2024, then increased 3.74% in 2025.
  • Year by year, Assets Average stood at $120.9 million in 2023, then soared by 105.68% to $248.6 million in 2024, then soared by 97.64% to $491.3 million in 2025.
  • Business Quant data shows Assets Average for IMNM at $491.3 million in Q4 2025, $297.8 million in Q3 2025, and $319.5 million in Q2 2025.